Centessa Pharmaceuticals Plc
(NASDAQ) CNTA
Centessa Pharmaceuticals Plc Financials at a Glance
Market Cap
$6.27B
Revenue (TTM)
$0.00
Net Income (TTM)
-$250.64M
EPS (TTM)
-$1.77
P/E Ratio
-22.82
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$40.55
Volume
0
Open
$40.15
Price
$40.55
Volume
0
Open
$40.15
Previous Close
$40.55
Daily Range
$40.00 - $40.55
52-Week Range
$12.75 - $40.56
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$40.55
Volume
0
Open
$40.15
Previous Close
$40.55
Daily Range
$40.00 - $40.55
52-Week Range
$12.75 - $40.56
Estimated Earnings Date
Aug 11, 2026
CNTA News
CNTA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Centessa Pharmaceuticals Plc
Industry
Biotechnology
Sector
Health CareEmployees
129
CEO
Mario Alberto Accardi, PhD
Website
centessa.comHeadquarters
Altrincham, WA14 2DT, GB
CNTA Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-60.37%
Return on Capital
-38.86%
Return on Assets
-39.05%
Earnings Yield
-4.38%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.27B
Shares Outstanding
154.73M
Volume
0
Avg. Volume
2.85M
Financials (TTM)
Gross Profit
-$238.60K
Operating Income
-$256.69M
EBITDA
-$260.55M
Operating Cash Flow
-$208.80M
Capital Expenditure
-$371.00K
Free Cash Flow
-$209.17M
Cash & ST Invst.
$276.59M
Total Debt
$7.37M
Centessa Pharmaceuticals Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$238.60K
-101.6%
Gross Margin
0.00%
N/A
Market Cap
$6.27B
N/A
Market Cap/Employee
$81.38M
N/A
Employees
77
N/A
Net Income
-$79.24M
-203.2%
EBITDA
-$75.43M
-248.5%
Quarterly Fundamentals
Total Cash
$276.59M
-2.8%
Total Debt
$7.37M
-93.8%
Accounts Receivable
$62.46M
+18.5%
Inventory
$0.00
N/A
Long Term Debt
$7.37M
-93.7%
Short Term Debt
$0.00
-100.0%
Return on Assets
-39.05%
N/A
Return on Invested Capital
-42.41%
N/A
Free Cash Flow
-$72.22M
-26.2%
Operating Cash Flow
-$72.22M
-26.2%